Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alan Peter Hill is active.

Publication


Featured researches published by Alan Peter Hill.


Journal of Medicinal Chemistry | 2013

Synthesis and Structure–Activity Relationships of Indazole Arylsulfonamides as Allosteric CC-Chemokine Receptor 4 (CCR4) Antagonists

Panayiotis A. Procopiou; John Barrett; Nicholas Paul Barton; Malcolm Begg; David E. Clapham; Royston C. B. Copley; Alison J. Ford; Rebecca H. Graves; David A. Hall; Ashley Paul Hancock; Alan Peter Hill; Heather Hobbs; Simon Teanby Hodgson; Coline Jumeaux; Yannick Maurice Louis Lacroix; Afjal H. Miah; Karen Morriss; Deborah Needham; Emma B. Sheriff; Robert J. Slack; Claire E. Smith; Steven L. Sollis; Hugo Staton

A series of indazole arylsulfonamides were synthesized and examined as human CCR4 antagonists. Methoxy- or hydroxyl-containing groups were the more potent indazole C4 substituents. Only small groups were tolerated at C5, C6, or C7, with the C6 analogues being preferred. The most potent N3-substituent was 5-chlorothiophene-2-sulfonamide. N1 meta-substituted benzyl groups possessing an α-amino-3-[(methylamino)acyl]-group were the most potent N1-substituents. Strongly basic amino groups had low oral absorption in vivo. Less basic analogues, such as morpholines, had good oral absorption; however, they also had high clearance. The most potent compound with high absorption in two species was analogue 6 (GSK2239633A), which was selected for further development. Aryl sulfonamide antagonists bind to CCR4 at an intracellular allosteric site denoted site II. X-ray diffraction studies on two indazole sulfonamide fragments suggested the presence of an important intramolecular interaction in the active conformation.


Drug Discovery Today | 2011

Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity

Robert J. Young; Darren V. S. Green; Christopher N. Luscombe; Alan Peter Hill


Archive | 1991

Therapeutic heterocyclic compounds

Alan Duncan Robertson; Alan Peter Hill; Robert Charles Glen; Graeme Richard Martin


Drug Discovery Today | 2010

Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity.

Alan Peter Hill; Robert J. Young


Journal of Medicinal Chemistry | 1995

Computer-Aided Design and Synthesis of 5-Substituted Tryptamines and Their Pharmacology at the 5-HT1D Receptor: Discovery of Compounds with Potential Anti-Migraine Properties

Robert C. Glen; Graeme Richard Martin; Alan Peter Hill; Hyde Rm; Woollard Pm; Salmon Ja; Buckingham J; Alan Duncan Robertson


Journal of Medicinal Chemistry | 2005

Dimeric Zanamivir Conjugates with Various Linking Groups Are Potent, Long-Lasting Inhibitors of Influenza Neuraminidase Including H5N1 Avian Influenza

Simon J. F. Macdonald; Rachel Cameron; Derek Anthony Demaine; Rob J. Fenton; Graham Foster; David Gower; J. Nicole Hamblin; Stephanie Hamilton; Graham J. Hart; Alan Peter Hill; Graham G. A. Inglis; Betty Jin; Haydn Terence Jones; Darryl Mcconnell; Jennifer L. McKimm-Breschkin; Gail Mills; Van T. T. Nguyen; Ian J. Owens; Nigel R. Parry; Stephen E. Shanahan; Donna L. Smith; Keith Geoffrey Watson; ‡ and Wen-Yang Wu; Simon P. Tucker


Journal of Medicinal Chemistry | 2001

Discovery of 4-[3-(trans-3-dimethylaminocyclobutyl)-1H-indol-5-ylmethyl]-(4S)-oxazolidin-2-one (4991W93), a 5HT1B/1D receptor partial agonist and a potent inhibitor of electrically induced plasma extravasation

Karamjit S. Jandu; Vikki Barrett; Michael Brockwell; David Cambridge; Duncan R. Farrant; Christopher James Foster; Heather Giles; Robert C. Glen; Alan Peter Hill; Heather Hobbs; Andrew Honey; Graeme Richard Martin; John Salmon; Donna Smith; and Patrick Woollard; David L. Selwood


Journal of Pharmaceutical Sciences | 2011

Estimating Unbound Volume of Distribution and Tissue Binding by In Vitro HPLC-Based Human Serum Albumin and Immobilised Artificial Membrane-Binding Measurements

Klara Valko; Shenaz Nunhuck; Alan Peter Hill


Journal of Medicinal Chemistry | 2017

Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruzi

Stephen Brand; Eun Jung Ko; Elisabet Viayna; Stephen Thompson; Daniel Spinks; Michael George Thomas; Lars Sandberg; Amanda Fortes Francisco; Shiromani Jayawardhana; Victoria Smith; Chimed Jansen; Manu De Rycker; John Thomas; Lorna MacLean; Maria Osuna-Cabello; Jennifer Riley; Paul Scullion; Laste Stojanovski; Frederick R. C. Simeons; Ola Epemolu; Yoko Shishikura; Sabrinia Crouch; Tania Bakshi; Christopher J. Nixon; Iain H. Reid; Alan Peter Hill; Tim Underwood; Sean J. Hindley; Sharon Robinson; John M. Kelly


Archive | 2011

DRUG DISCOVERY INTERFACE Estimating Unbound Volume of Distribution and Tissue Binding by In Vitro HPLC-Based Human Serum Albumin and Immobilised Artificial Membrane-Binding Measurements

Ara L. Valk; Shenaz Nunhuck; Alan Peter Hill

Collaboration


Dive into the Alan Peter Hill's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge